This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2023 — Pharmaceutical Compliance Congress


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
April 25 - 27, 2023The Ritz-Carlton, Tysons Corner | McLean, VA

Kays Sawaged
Head of Compliance & Ethics at BioXcel Therapeutics


Kays Sawaged is Head of Compliance & Ethics at BioXcel Therapeutics, a commercial-stage biopharmaceutical company focused on artificial intelligence-based drug development in neuroscience and immuno-oncology. Kays is responsible for implementing and overseeing BioXcel Therapeutics’ first comprehensive Healthcare Compliance & Ethics program, which is focused on preparation for FDA approval and product commercialization. Before joining BioXcel Therapeutics, Kays held various compliance roles with companies like Novartis, Sanofi, and Daiichi Sankyo.

Kays holds a Bachelor of Science in Finance and a Master’s in Business Administration from Montclair State University. Kays is a Certified Compliance & Ethics Professional and a Certified Fraud Examiner.

Agenda Sessions

  • Product Launch Considerations —Creating a Pre-Commercial Compliance Checklist